New publication on DECORIN, a triceps-derived myokine, and type 2 diabetes on Acta Physiol (Oxf)
Janvier 30 2025
"DECORIN, a triceps-derived myokine, protects sorted β-cells and human islets against chronic inflammation associated with type 2 diabetes"
Langlois A, Cherfan J, Meugnier E, Rida A, Arous C, Peronet C, Hamdard H, Zarrouki B, Wehrle-Haller B, Pinget M, Craige SM, Bouzakri K
A good news to start the year: CeeD laboratory reveals a new publication in Acta Physiologica journal
- In this paper, the research team shows that DECORIN, a new triceps-derived myokine, has a beneficial effect on human pancreatic islets, protecting them from cell death induced by inflammation.
- This work demonstrates for the first time that DECORIN restores T2D-islet function and reverses the expression of T2D-associated genes.
- Based on these datas, they propose DECORIN as a promising therapeutic target for diabetes-associated inflammation and diabetes itself.
Our previous news
April 1-4 2025
CeeD, Vaincre le diabète, and its spin-off, Ilonov and CEED Formation, wish you a happy new year. A little touch of humor to start 2025… This year, we asked AI to generate our greeting card. Our instructions: represent our fight against diabetes and carry a message of hope, unity and innovation. According to the tool, this scene would harmoniously illustrate research, patient care and health professionals training. We let you judge the result 😉 Thank you for your support and your generosity.
